Entry |
|
Name |
PDL/PD1-SHP-PI3K signaling pathway
|
Definition |
(PDL1,PDL2) -> PDCD1 -> SHP1/2 -| PI3Kdelta |
Expanded |
(29126,80380) -> 5133 -> (5777,5781) -| (5293+(5295,5296,8503)) |
Class |
|
Type |
Reference
|
Pathway |
hsa04660 | T cell receptor signaling pathway |
|
Gene |
29126 | CD274; CD274 molecule |
80380 | PDCD1LG2; programmed cell death 1 ligand 2 |
5133 | PDCD1; programmed cell death 1 |
5777 | PTPN6; protein tyrosine phosphatase non-receptor type 6 |
5781 | PTPN11; protein tyrosine phosphatase non-receptor type 11 |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5295 | PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 |
5296 | PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 |
8503 | PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 |
|
Reference |
|
Authors |
Sharpe AH, Pauken KE |
Title |
The diverse functions of the PD1 inhibitory pathway. |
Journal |
|
Reference |
|
Authors |
Buchanan CM, Lee KL, Shepherd PR |
Title |
For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors. |
Journal |
|
Reference |
|
Authors |
McBride MA, Patil TK, Bohannon JK, Hernandez A, Sherwood ER, Patil NK |
Title |
Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression. |
Journal |
|
Reference |
|
Authors |
Chinai JM, Janakiram M, Chen F, Chen W, Kaplan M, Zang X |
Title |
New immunotherapies targeting the PD-1 pathway. |
Journal |
|
LinkDB |
|